Evaluation of event-free survival as a surrogate for overall survival in early-stage triple-negative breast cancer following neoadjuvant therapy - Fasching, Peter; Huang, M.; Haiderali, A.; Xue, W.; Pan, W.; Karantza, V.; Yang, F.; Truscott, J.; Xin, Y.; O'Shaughnessy, J. (ANNALS OF ONCOLOGY, 2022)
CRIS-Team WoS Importer:2022-12-23